Clinical Recommendations 2017 Hypertension Clinical Practice Guidelines4 Recommendation for Accurate Measurement of BP in the Office (Guideline Section 4) For diagnosis and management of high BP, proper methods are recommended for accurate measurement and documentation of BP. (Class 1, Level of Evidence: C-EO) ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; CDU, care delivery unit; DBP, diastolic blood pressure; HCO, home care organization; QCDR, Qualified Clinical Data Registry; and SBP, systolic blood pressure. Appendix A. Continued 34 Appendix A. Continued SM-2: Use of a Standard Process for Assessing ASCVD Risk Measure Components The CDU uses a standard process/protocol for properly measuring/assessing ASCVD risk, including: 1. Measurement of ASCVD Risk a. Use of ACC/AHA Risk Estimator139,140 is recommended. Others may be used as alternatives when evaluated in the population seen clinically. b. Healthcare providers identify the health provider responsible for insuring competency and implementation of risk assessment in practice. 2. Incorporation Into Record a. Baseline risk should be part of patient demographics and included in each note when BP is 130 139/80 89 mmHg, with indication of how it is used in defining treatment strategy. b. EMR for systems (eg, Epic, Cerner) should be requested to automatically place cardiovascular risk assessment in the patient record as part of vital signs. 3. Confirmation of Patient Clinician Discussion a. The risk assessment used in the patient clinician discussion should be entered 1) directly by EHR (eg, Epic, Cerner) or 2) by physician or other healthcare provider as part of documentation of the discussion. b. 